Given the data from a colorectal cancer model showing that metastases are more reliant on Lgr5+ CSCs than primary tumours [29] it will be interesting to see if PDAC primary tumours and metastases react differently to CSC ablation, especially given that metastases are the main cause of patient mortality [40]. The gene discussed is LGR5; the disease is neoplasm.